Human N-myc downstream-regulated gene 2 (NDRG2) has been shown to be a multifunctional protein associated with cell proliferation, differentiation, transmembrane transport, and stress responses. In most mammalian brains, NDRG2 is principally expressed in astrocytic cells throughout different regions. NDRG2 has been increasingly implicated in the regulation of neurogenesis and in the development of nervous system diseases, including neurodegeneration, ischemia, and glioblastoma. This review summarizes the distribution and subcellular localization of NDRG2 in brain tissues, highlights the physiological actions of NDRG2 in the nervous system, and further discusses the roles of NDRG2 during the occurrence and development of several nervous system diseases.
Introduction
Human N-myc downstream-regulated gene 2 (NDRG2; GenBank accession No. AF159092) was first discovered and cloned by Deng et al. [1] from a polymerase chain reaction-based subtractive hybridization method. It locates on chromosome 14q11.2 and consists of 16 exons and 15 introns [1, 2] . NDRG1, NDRG2, NDRG3, and NDRG4 compose the NDRG gene family, a class of NDRGs [3] . Accumulating studies have shown the important roles of this family in cell multiplication, differentiation, and stress [3] [4] [5] .
NDRG2 mRNA has been found in dozens of alternative splice forms, which encode six types of protein isoforms [2, 6] . The fulllength human NDRG2 protein consists of 371 amino acid residues, and its molecular mass is 40 kDa. The NDRG2 protein possesses α/ β hydrolase-fold motifs that are characterized to be shared in other NDRG members [2, 4] . Additionally, an acyl carrier protein-like domain was found in the NDRG2 protein via a bioinformatic analysis [1] . The NDRG2 protein contains several phosphorylation sites (Thr330, Ser332, Thr348, T330, T334, etc.), which can be phosphorylated by its upstream kinases (Akt and serum-and glucocorticoid-induced kinase 1, etc.) in certain cells [7] [8] [9] . NDRG2 protein can be detected in most embryonic and adult tissues by specific antibodies, especially in highly differentiated tissues, such as the brain, heart, muscle, and sialaden [4] . The abundance of NDRG2 is inversely associated with the ability of cells to proliferate [4] . Intensive research has focused on NDRG2 due to its function as a tumor suppressor [4, 10, 11] .
Although NDRG2 has been repeatedly reported to be widely expressed in the brain at high levels and to participate in a variety of pathological processes in the nervous system [12] [13] [14] [15] [16] [17] , the biological functions of NDRG2 in the nervous system are very complicated and have not been fully clarified [4] . This review focuses on NDRG2's distribution, physiological function, and transcriptional regulatory mechanisms, as well as on some of its pathological processes in the nervous system. cerebrum, NDRG1 and NDRG2 are mainly expressed in oligodendrocytes and astrocytes, respectively, whereas NDRG3 and NDRG4 are ubiquitously localized. In the cerebellum, NDRG1 and NDRG4 were detected in Purkinje neurons, but NDRG2 positive staining was primarily found in Bergmann glial cells. Subcellular localization is not the same among NDRG proteins. NDRG1, NDRG2, and NDRG4 are mainly present in the cytoplasm, while NDRG3 locates in nuclei in most cells [20] . In addition, transcripts of NDRG family members in the adult human and mouse brain are significantly higher than those in the fetal brain, which indicates that the NDRG family may play a potential role in neurodevelopment [13, 15] .
NDRG2 was found to be predominately and selectively expressed in glial cells, especially astrocytes, but not in neurons or microglia because NDRG2 can co-localize with the majority of the known astrocytic marker proteins, such as S100β and glial fibrillary acidic protein (GFAP) [20, 21] . Recently, Flugge et al. [21] detected the distribution pattern of NDRG2 in several mammalian brains, including human, marmoset, tree shrew, rat, and mouse brains, and suggested that NDRG2 is a new extensive and specific marker for a vast majority of mature and nonreactive astrocytes. The expression of NDRG2 is gradually increased during postnatal development in both human and murine brains ( Table 1 ) [17] . In the embryonic mouse brain, Hu et al. [15] observed that positive NDRG2 immunoreactivity is present in the outer layer of the cortex, choroid plexus, and epidermis (E14.5-E17.5). The transcription of NDRG2 is gradually increased during the development of the central nervous system, because the increase was found in the telencephalon, diencephalon, mesencephalon, metencephalon, spinal cord, and cortical ventricular zone at different embryonic stages in mice [22] . Consistent with the studies of fetal mice, the NDRG2 gene and its corresponding protein are distributed throughout the adult mouse brain, but the high expression regions are different [15, 22, 23] (Table 1 ). In the rat brain, NDRG2 mRNA is also widely expressed, but it is more abundant in gray matter than in white matter and is limited to GFAP-positive astrocytes or radial glia [16] . In the human brain, northern blots were performed to examine the NDRG2 transcription pattern. NDRG2 mRNA was detected in the cerebral cortex, striatum, cerebellum, brainstem, and spinal cord. In addition, subcellular localization studies showed that NDRG2 protein is mainly expressed in the cytoplasm [12, 17, 20, 23] and some cell surface membranes [21, 24, 25] . NDRG2 protein was also found in nuclei or was transferred into nuclei from the cytoplasm under certain cell stress conditions [15, 23, 24, 26] (Table 1) . A middle fragment of the NDRG2 protein (101-178 amino acids) was demonstrated to be responsible for its nuclear translocation, but no nuclear localization signal sequence was identified in this protein [27] .
Taken together, the specific cellular and subcellular localization of NDRG2 in the nervous system under various biological conditions indicates that NDRG2 may have different functions in the different locations.
Control of NDRG2 Expression in the Nervous System
Bioinformatics analysis predicted that there are several binding sequences of NDRG2 in different transcription factors [2] , including p53 [26, 28] , hypoxia-induced factor-1α (HIF-1α) [27] , Wilms' tumor gene 1 (WT1) protein [14] , estrogen [29] , androgens [30] , aldosterone [6, 16] , and glucocorticoids [16, 31] , and all these binding sequences were verified by subsequent experimental studies. An increased C-myc mRNA level was found to be associated with reduced NDRG2 mRNA in some human glioblastoma tissues and cell lines Table 1 . Nervous system distribution and localization of NDRG2
Species Distribution References
Distribution pattern
Mouse
The outer layer of the cortex, choroid plexus, and epidermis of embryonic mice.
[15] Throughout the developing central nervous system of embryonic mice, including the telencephalon, diencephalon, mesencephalon, metencephalon, and spinal cord. Highly expressed in the cortical ventricular zone at various embryonic stages. Present in postmitotic neurons of the embryonic retina and spinal cord. [22] The cerebral cortex, olfactory bulb, midbrain, hippocampus, and thalamus. High levels in the lateral ventricle and hippocampal dentate gyrus. Localized to GFAP-positive radial glia cells in the subventricular zone and subgranular zone. [22] Localized to astrocytes in the cerebrum and to Bergmann glial cells in the cerebellum.
[20] Throughout the adult mouse brain. Particularly in the midbrain, cerebellum, and pons.
[15]
The cerebral cortex, olfactory bulb, midbrain, hippocampus, and thalamus. High levels in the midbrain and thalamus.
[23]
Rat
Throughout the brain. More abundant in gray matter than in white matter. Localized to GFAP-positive astrocytes or radial glia.
[16]
Human Most areas of the cerebral cortex, striatum, cerebellum, brainstem, and spinal cord.
[17] Subcellular localization Mouse Perinuclear in the 6E12 cell line and in the cytoplasm of brain cells.
[17] Cytoplasm of cells in the cerebral cortex, olfactory bulb, midbrain, hippocampus, and thalamus.
[23] Cytoplasm of cortical and cerebellar cells.
[16] Both the cytosol and cell membranes in the mouse striatum. Nuclear localization was weakly observed in the mouse striatum.
[24]
Nuclei of midbrain cells, possibly gliocytes.
[15] Nuclei of many cells with astrocyte-like morphology in the hippocampus and cerebral cortex.
[23] Rat
Cell surface membranes of NGF-differentiated PC12 cells.
[25] Both the cytosol and the cell membranes of astrocytes.
[24] Translocated from the cytoplasm to the nucleus after OGD exposure. [26] [12], and it has been reported that the expression of human NDRG2 is down-regulated by C-myc via transcriptional inhibition in HeLa and HEK 293 cells [32] . Intriguingly, the expression of NDRG2 was not obviously elevated in N-myc knockout embryos [33] . To date, glucocorticoids [16, 31] , p53 [26] , and estrogen [34] have been demonstrated to regulate NDRG2 transcription in the nervous system. After adrenalectomy, the transcription of NDRG2 was obviously increased in the hippocampus with glucocorticoid treatment compared with sham-operated rats. NDRG2 mRNA was also upregulated by glucocorticoids in both the cerebral cortex and cultured astrocytes in vitro [16] . Dexamethasone, a common analog of glucocorticoids, can induce increased NDRG2 expression in astrocytes, and this effect can be blocked by pretreatment with the glucocorticoid receptor antagonist RU486. The potential glucocorticoid-binding site on the NDRG2 promoter was analyzed by a technology involving progressively deleted promoter constructs. NDRG2 expression was found to be indirectly induced by dexamethasone, potentially via the binding of nuclear factor-kappa B and paired box 5 to the transcription-factor-binding sites of NDRG2 [31] . In contrast, another study revealed that the down-regulation of NDRG2 and GFAP in diabetic rats was rescued by a 9-day administration of the glucocorticoid receptor blocker RU486 [35] . NDRG2 was first reported to be involved in p53-mediated apoptosis in a human lung cancer cell line, A549 [28] . NDRG2 was also identified as a p53 target in C6-originated astrocytes, in which p53 silencing inhibited NDRG2 expression. However, exogenous over-expression of p53 did not further promote the up-regulation of NDRG2 transcription [26] . In an estrogen-related study, NDRG2 mRNA and protein expression were shown to be up-regulated by an estrogen receptor agonist in primary cultured astrocytes, and the decreased expression of NDRG2 in the hippocampus of ovariectomized female mice was reversed by the injection of an estrogen receptor agonist [34] . In addition to glucocorticoids, p53, and estrogen, other transcription factors that regulate NDRG2, such as WT1 [36] , HIF-1α [37] , androgens [38] , and aldosterone [39] , also have important effects on the nervous system. Further studies should be carried out to investigate whether these transcription factors play critical roles in the nervous system by regulating NDRG2 expression.
Physiological Functions of NDRG2 in the Nervous System
The functions of NDRG2 in the central nervous system involve cell proliferation, neurogenesis, and stress responses to psychosocial stress and trauma ( Table 2) .
Silencing of the NDRG2 gene in astrocyte cultures in vitro showed a significant enhancement of the number of proliferating cell nuclear antigen (PCNA)-positive and 5-bromo-2′-deoxyuridine (BrdU)-incorporating cells. However, both the length of the astrocytic processes and the amount of F-actin were reduced accordingly. In contrast, the number of PCNA-positive and BrdU-incorporating cells was prominently reduced and the F-actin expression was enhanced with the treatment of adenovirus-mediated over-expression of NDRG2 [24] . Interestingly, when exogenous NDRG2 was over-expressed in nerve growth factor (NGF)-differentiated PC12 cells, it was specifically localized to cell surface membranes and growth cones [25] . Furthermore, NDRG2 staining in the distal astrocytic processes is closely related to the nerve terminal markers, which suggests that NDRG2 may play a role in synaptic transduction and in neurite sprouting, extension, and guidance [21] . Altogether, these studies demonstrated NDRG2 as an important molecule in the suppression of cell proliferation and in the stabilization of cell morphology that determines astroglial activation.
NDRG2 expression was found to be increased in astrocytic C6 cells during the process of differentiating into astrocytes [23] . In the rat brain, NDRG2 mRNA was found to be primarily expressed in neurogenic regions and co-localized with GFAP staining [16] . In situ hybridization in the mouse brain showed the expression of NDRG2 mRNA in neurogenic zones throughout life. NDRG2 mRNA is colocalized with the cell proliferation markers BrdU and Ki67 and also with the neural progenitor cell marker Nestin [22] . Together, these data suggest that NDRG2 plays a role in neural cell differentiation and neurogenesis.
Studies of rat brain tissue revealed reduced GFAP and up-regulated NDRG2 protein levels under chronic psychosocial stress [40] . However, in a cortical stabbing injury model in mice, both GFAP and NDRG2 were elevated, and NDRG2 showed a stress responsiveness that was related to the early astroglial activation, reactive astrogliosis, and the subsequent inflammatory response, at least in part, via the activation of IL-6/STAT3 inflammatory signaling [41] . Overall, these NDRG2 may regulate astroglial activation through the suppression of cell proliferation and the stabilization of cell morphology.
Differentiation and development NGF-differentiated PC12 cells NDRG2 protein was specifically localized to cell surface membranes and growth cones. NDRG2 over-expression promoted neurite elongation. [25] C6 rat glioma cells NDRG2 expression was increased in glioma cells that were differentiating into astrocytes.
Rat brain NDRG2 mRNA was predominately expressed in neurogenic regions of the rat brain, where it was localized to GFAP-positive glia.
Mice brain NDRG2 mRNA was expressed in neurogenic zones throughout life. NDRG2 was expressed in proliferating precursor cells.
[22]
Stress response Rat brain NDRG2 was up-regulated during chronic psychosocial stress, but the mechanisms remain to be elucidated.
[40]
Mice brain NDRG2 is an injury-responsive gene that is involved in the early phase of astroglial activation and positively regulates reactive astrogliosis and the subsequent inflammatory response.
[ 41] findings demonstrated that NDRG2 is an early-stage stress-responsive gene and is correlated with astroglial activation and the subsequent inflammatory reaction. Whether the NDRG2-mediated cell stress response is an endogenous neural protection mechanism or is involved in pathological injury remains to be elucidated.
NDRG2 and Nervous System Diseases
Accumulating studies have shown that NDRG2 is associated with certain nervous system diseases, including brain tumors, ischemic stroke, and neurodegenerative disorders ( Table 3) . Deng et al. [12] first found that the transcription level of human NDRG2 was significantly reduced in human glioblastoma tissues and human glioblastoma cell lines, while exogenous over-expression of NDRG2 repressed glioblastoma cell proliferation in vitro. Similar studies also repeatedly reported that NDRG2 is down-regulated in a variety of brain tumors, including glioma and meningioma [42] [43] [44] [45] [46] [47] . Although direct structural alterations such as point mutations are very rare in the NDRG2 gene, hypermethylation of the NDRG2 promoter region was shown to be highly correlated with decreased NDRG2 transcription levels in human astrocytic gliomas [42] . In addition to the hypermethylation of NDRG2 per se, NDRG2 may control glioma cell growth by up-regulating histone acetylation in glioma cells [43] . It was also found that the expression level of NDRG2 was negatively correlated with the pathological grade of the brain tumors and positively correlated with the survival in astrocytoma patients [44, 45] . Consistent with the glioblastoma results, decreased NDRG2 protein levels and hypermethylation of the NDRG2 promoter were detected in human meningioma [46] . Moreover, NDRG2 expression was further reduced significantly in recurrent meningioma tissues when compared with primary meningioma tissues [47] . These results indicate that NDRG2 may serve as a potential prognostic biomarker for human brain tumors.
All of the NDRG family members are abundantly expressed in brain tissue. Therefore, the significant roles of these proteins were expected and have been verified by studies in NDRG-deficient mice [48, 49] . NDRG1 knockout mice exhibit a progressive demyelinating disorder of the peripheral nerves, which suggests that NDRG1 is essential for the maintenance of myelin sheaths in peripheral nerves [48] . NDRG4-deficient mice show impaired cognition and increased susceptibility to ischemic stroke, which indicates that NDRG4 has a potential neuroprotective effect [49] . Although the effect of NDRG2 in cerebral ischemia remains to be revealed by a genetic deficiency model, NDRG2 is implicated in the ischemic stress response in several studies [26, [50] [51] [52] . Temporal and spatial expressions of NDRG2 in the rat brain have been investigated after transient middle cerebral artery occlusion. Both mRNA and protein levels of NDRG2 were increased at 4 h and peaked at 24 h following reperfusion in the ischemic penumbra, and NDRG2 was translocated from the cytoplasm to the nucleus in astrocytes at 24 h. NDRG2 expression was also increased in parallel with the enhancement of TUNEL-positive signals in this ischemic animal model [50] . Consistent with animal-based experiment described above, NDRG2 was also found to be up-regulated and translocated from the cytoplasm to the nucleus in C6-originated astrocytes treated with oxygen-glucose deprivation (OGD) which mimics ischemia in vitro [26] . In addition, NDRG2 has also been involved in some types of pretreatment-induced cerebral ischemic tolerance, such as electroacupuncture (EA) [52] and sevoflurane [51] . When EA pretreatment at the Baihui acupoint was performed before the induction of transient focal cerebral ischemia, the infarction volume and the number of apoptotic cells were decreased, while neurological scores were effectively improved. After the induction of ischemia, NDRG2 protein was mainly increased in the EA pretreatment group and was located in the cytoplasm of astroglia, with only weak staining found in the nucleus. However, NDRG2 protein was notably translocated from the cytoplasm into the nucleus in the nopretreatment group [52] . Recently, sevoflurane preconditioning was also found to have an NDRG2-mediated protective effect in a brain ischemia model both in vivo and in vitro [51] . These results indicate that NDRG2 participates in the pathological process of brain ischemia-reperfusion and that NDRG2 may be a potential target for neuroprotection during cerebral ischemia.
NDRG2 has also been reported to be associated with other nervous system diseases, such as neurodegenerative and depressive disorders. NDRG2 was identified as one of six abnormally phosphorylated proteins and exhibited an increased number of phosphospectra in human brain tissues with degeneration of the frontotemporal lobe [53] . Mitchelmore et al. [17] investigated postmortem brain tissues from Alzheimer's disease (AD) patients and found the up-regulation of NDRG2 and GFAP in cortical senile plaques. A recent study also demonstrated that NDRG2 and GFAP protein levels were increased in an AD transgenic mouse model [54] . Improved memory deficits and suppressed NDRG2 expression were detected in parallel after EA administration in the AD transgenic mice. Furthermore, the expression of NDRG2 was increased in reactive astrocytes after mice were exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a Parkinson's disease-related neurotoxin that induces both glial activation and neurodegeneration [24] . Moreover, accumulating researches have demonstrated that NDRG2 is involved in the function of antidepressants, which can normalize the behavior and alleviate some of the neural changes observed in depression-like animals [16, 40, 55] . Takahashi et al. [55] reported that NDRG2 was down-regulated by the chronic use of antidepressants in normal rat frontal cortex. In contrast to result described above, Araya-Callis et al. [40] reported that antidepressants did not counteract the increase in NDRG2 expression in the hippocampus of stress-induced depression-like rats and that antidepressants per se could induce NDRG2 expression in normal rats. It will be interesting to further study the detailed mechanisms by which NDRG2 participates in these neurodegenerative or chronic psychosocial diseases and to provide novel intervention strategies.
Conclusions and Perspectives
Increasing knowledge of NDRG2 in the brain is helpful to understand its function in complicated physiological and pathological conditions. Although NDRG2 is widely expressed in the brains of mice, rats, and human, it is specifically localized to the cytosol of astrocytes under most physiological conditions. This selective expression pattern indicates the potent effect of NDRG2 in astrocytes, which play critical roles in protecting, supporting, and interacting with neurons. In addition to the relatively well-known role of NDRG2 in cell proliferation and differentiation, this review highlights the role of NDRG2 in mediating stress reactions in the nervous system, including responses to ischemia, trauma, and neurotoxins. Whether the NDRG2-mediated cell stress response is an endogenous neural protection mechanism or is involved in pathological injury remains to be elucidated and may depend on various biological conditions. Additionally, accumulating studies suggest that aberrant NDRG2 expression or localization is involved in certain brain diseases, such as brain tumors, ischemic cerebral stroke, AD, and chronic depression. Further studies of NDRG2 in the nervous system are needed to reveal the largely unknown mechanisms, which will help to provide new therapeutic intervention strategies for brain tumors and other neurological disorders.
